Association of the GRIN2B rs2284411 polymorphism with methylphenidate response in attention-deficit/hyperactivity disorder. (August 2017)
- Record Type:
- Journal Article
- Title:
- Association of the GRIN2B rs2284411 polymorphism with methylphenidate response in attention-deficit/hyperactivity disorder. (August 2017)
- Main Title:
- Association of the GRIN2B rs2284411 polymorphism with methylphenidate response in attention-deficit/hyperactivity disorder
- Authors:
- Kim, Johanna I
Kim, Jae-Won
Park, Jong-Eun
Park, Subin
Hong, Soon-Beom
Han, Doug Hyun
Cheong, Jae Hoon
Choi, Jae-Won
Lee, Sumin
Kim, Bung-Nyun - Abstract:
- Objective: We investigated the possible association between two NMDA subunit gene polymorphisms (GRIN2B rs2284411 and GRIN2A rs2229193) and treatment response to methylphenidate (MPH) in attention-deficit/hyperactivity disorder (ADHD). Methods: A total of 75 ADHD patients aged 6–17 years underwent 6 months of MPH administration. Treatment response was defined by changes in scores of the ADHD-IV Rating Scale (ADHD-RS), clinician-rated Clinical Global Impression—Improvement (CGI-I), and Continuous Performance Test (CPT). The association of the GRIN2B and GRIN2A polymorphisms with treatment response was analyzed using logistic regression analyses. Results: The GRIN2B rs2284411 C/C genotype showed significantly better treatment response as assessed by ADHD-RS inattention ( p =0.009) and CGI-I scores ( p =0.009), and there was a nominally significant association in regard to ADHD-RS hyperactivity-impulsivity ( p =0.028) and total ( p =0.023) scores, after adjusting for age, sex, IQ, baseline Clinical Global Impression—Severity (CGI-S) score, baseline ADHD-RS total score, and final MPH dose. The GRIN2B C/C genotype also showed greater improvement at the CPT response time variability ( p <0.001). The GRIN2A G/G genotype was associated with a greater improvement in commission errors of the CPT compared to the G/A genotype ( p =0.001). Conclusions: The results suggest that the GRIN2B rs2284411 genotype may be an important predictor of MPH response in ADHD.
- Is Part Of:
- Journal of psychopharmacology. Volume 31:Number 8(2017)
- Journal:
- Journal of psychopharmacology
- Issue:
- Volume 31:Number 8(2017)
- Issue Display:
- Volume 31, Issue 8 (2017)
- Year:
- 2017
- Volume:
- 31
- Issue:
- 8
- Issue Sort Value:
- 2017-0031-0008-0000
- Page Start:
- 1070
- Page End:
- 1077
- Publication Date:
- 2017-08
- Subjects:
- Attention-deficit/hyperactivity disorder -- glutamate receptors -- methylphenidate -- pharmacogenetics
Psychopharmacology -- Periodicals
615.78 - Journal URLs:
- http://jop.sagepub.com/ ↗
http://www.uk.sagepub.com/home.nav ↗ - DOI:
- 10.1177/0269881116667707 ↗
- Languages:
- English
- ISSNs:
- 0269-8811
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 8389.xml